Cerebral Abnormalities Detected by MRI, Realized at the Age of Term and the Emergence of Executive Functions
NCT ID: NCT02083822
Last Updated: 2014-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
600 participants
INTERVENTIONAL
2011-06-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These children present high risk of deficits such as cognitive deficits, adaptive malfunction, behavior disorders and difficulties in school learning.
Understanding the specific neuropsychological disorders at the origin of these deficits is an important objective. Studies realized at school age showed that many premature children have executive functions (EF) disorders. However the specific nature of these disorders and the neuropathology associated are unknown.
The aim of this study is to realise MRI at term age in preterm babies born less than 32 GA and to correlate MRI findings with executives functions and neurodevelopmental outcome
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Brain Plasticity in Premature Infants at School Age After Cognitive Remediation
NCT03972761
Cerebral Magnetic Resonance Spectroscopy at Term Corrected Age and Dysexecutive Syndrome in Very Preterm Children at 5.5-years-old
NCT06055062
Childhood Outcomes of Preterm Brain Abnormalities
NCT03410810
Cerebral Function Monitoring in Premature Infants
NCT00873847
Brainstem and Prematurity
NCT02669056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the age of 5 years, executive functions and neurodevelopmental testing would be realized.
600 newborns were recruited.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI assessment
term MRI, executive EF functions testing
An MRI will be realized at term born between 25 and 32 weeks GA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
term MRI, executive EF functions testing
An MRI will be realized at term born between 25 and 32 weeks GA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* born between 25 and 32 WGA
* hospitalized in a neonatology service which participate to the present study
* included in EPIPAGE 2 follow-up study
* infants whose parents had signed the consent agreement and benefit from national health insurance
Exclusion Criteria
25 Weeks
32 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Neurologie Pédiatrique
Angers, , France
Service de Néonatologie
Bordeaux, , France
Service de Néonatologie
Caen, , France
Médecine Néonatale et Réanimation Pédiatrique
Grenoble, , France
Service de REANIMATION NEONATALE ET PEDIATRIQUE, NEONATOLOGIE
Le Kremlin-Bicêtre, , France
Service de Néonatologie
Lille, , France
Médecine Infantile - Néonatologie - Périnatologie
Marseille, , France
Service de Néonatalogie
Marseille, , France
Service de Néonatologie
Nancy, , France
Service de Néonatologie
Nantes, , France
Réanimation néonatale et Néonatologie
Paris, , France
Service de Réanimation, Néonatologie
Reims, , France
Service de Néonatologie
Rennes, , France
Service de Pédiatrie Néonatale et Réanimation
Rouen, , France
Service de Réanimation pédiatrique, Néonatologie
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRN11-ES / EPIRMEX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.